AB&B BIO-TECH-B 02627Hong Kong Stock Exchange

Suspended: Oct 9 · Delayed · Hong Kong Stock Exchange
AB&B BIO-TECH-B (02627) Company Profile - Company Info, Industry & Management - cibo

Company Information

Company Name
Ab&B Bio-Tech Co., Ltd.
Market
HKEX Main Board
Listing Date
2025-08-11
Industry
Innovative Drugs & Biologics
Fiscal Year End
Dec 31
ISIN
CNE1000071P9
Southbound Connect
Shanghai · Shenzhen

Industry

Innovative Drugs & Biologics 0.02%
124 stocks in this industry
Down 52 Up 57
Industry RankingsValue (HKD)Rank
ROE (Last FY)-176.49%115/117

Change is the 2026-10-09 close against the previous close; the industry change is the equal-weighted average of its stocks. Sub-industry classification is maintained by cibo. Last FY is each company's latest annual report. Net profit is profit attributable to owners of the parent; ROE = net profit / closing equity attributable to owners. Non-HKD statements are converted at ECB reference rates.

Management

NamePosition
安有才 Executive Director
李润香 Executive Director
何一鸣 Executive Director
于建林 Non-Executive Director
杜沐 Non-Executive Director
李向明 Independent Non-Executive Director
李建军 Independent Non-Executive Director
陈乘贝 Independent Non-Executive Director
雷美嘉 Independent Non-Executive Director

Board list from the HKEXnews "List of Directors and their Role and Function", as of 2026-05-27.

About this page

This page shows AB&B BIO-TECH-B (02627) company information, related securities, the price change distribution and in-industry rankings within its sub-industry, and the board of directors. Quotes come from HKEX Daily Quotations, financial metrics from each company's latest annual report, and the director list from HKEXnews.